Brain and Spine (Jan 2022)
Screening for Degenerative Cervical Myelopathy (SCREEN-DCM) in patients based on signs, symptoms and known risk factors: preliminary results of an ongoing prospective multicenter study
- A. Nouri,
- G. Molliqaj,
- A. Lave,
- G. Jannelli,
- B. Davies,
- M. Kotter,
- A. Martin,
- J. Virojanapa,
- J. Cheng,
- T. Somma,
- P. Cappabianca,
- C. Vleggeert-Lankamp,
- V. ter Wengel,
- K. Schaller,
- E. Tessitore
Affiliations
- A. Nouri
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- G. Molliqaj
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- A. Lave
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- G. Jannelli
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- B. Davies
- University of Cambridge, Neurosurgery, Cambridge, United Kingdom
- M. Kotter
- University of Cambridge, Neurosurgery, Cambridge, United Kingdom
- A. Martin
- University of California Davis, Neurosurgery, Sacramento, United States
- J. Virojanapa
- University of Cincinnati, Neurosurgery, Cincinnati, United States
- J. Cheng
- University of Cincinnati, Neurosurgery, Cincinnati, United States
- T. Somma
- University of Naples Federico II, Neurosurgery, Naples, Italy
- P. Cappabianca
- University of Naples Federico II, Neurosurgery, Naples, Italy
- C. Vleggeert-Lankamp
- Leiden University, Neurosurgery, Leiden, Netherlands
- V. ter Wengel
- Leiden University, Neurosurgery, Leiden, Netherlands
- K. Schaller
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- E. Tessitore
- Geneva University Hospitals, Neurosurgery, Geneva, Switzerland
- Journal volume & issue
-
Vol. 2
p. 101447
